The medical professional that manages the ovarian cancer patient impacts the quality.
Ads by Google
Women treated for ovarian cancer are at increased risk of a rapid and potentially fatal recurrence if their tumor cells have high levels of a binding protein that triggers abnormal growth.
The risk of developing ovarian cancer is 60 percent lower among women living in areas of the world with high ultraviolet B radiation exposure than those who live in areas with less UVB, concludes a study encompassing 175 countries.
"The main reason for this advantage is that women living in sunny areas have higher circulating (vitamin D2) levels that protect them from ovarian cancer," said lead researcher Dr. Cedric Garland, a professor of family and preventive medicine at the University of California in San Diego.
Treatment of ovarian cancer requires multi modality approaches including surgery and chemotherapy, but a small number of patients may benefit from radiofrequency ablation instead of repeated surgery
Viruses tailored to fight ovarian cancer can now be tested in clinical trials, thanks to new research.
If a woman under 45 has ovarian cancer or a benign disease in the ovaries that requires removal, however, compelling reason remains to remove the ovaries.
Nanoparticles slip through blood vessel pores to attack ovarian cancer tumor cells.
Women with mutations in the BRCA1 or BRCA2 genes can significantly reduce their risk of certain types of cancer by having their ovaries removed.
Using paracetamol regularly could reduce the risk of ovarian cancer by almost a third.
As a first course of treatment, ovarian cancer typically is treated with surgery followed by a regimen of the chemotherapy drug cisplatin.
Research identified a combination of several biomarkers that could help detect ovarian cancer much earlier than it is currently being diagnosed.
Accurate interpretation of test results could ultimately help to save the lives of postmenopausal women who do not present with symptoms but have ovarian cancer.
While ovarian cancer accounts for only 6% percent of all cancers among women, its mortality rate is very high, ranking it the fourth highest cancer killer of women.
Women with Stage III ovarian cancer given a combination of intravenous and intraperitoneal chemotherapy following surgical debulking of tumor had a median survival nearly 16 months longer than women who received IV chemotherapy alone, according to a study published conducted by the Gynecologic Oncology Group (GOG), a National Cancer Institute-supported research network, in the January 5, 2006 issue of the New England Journal of Medicine.
Study led by Johns Hopkins Kimmel Cancer Center suggests new treatment standard for advanced ovarian cancer.
Surgery to remove as much tumor as possible at the initial operation is the best option for most patients with ovarian cancer.
Ovarian conservation at the time of hysterectomy (in women who are not at increased risk for ovarian cancer) may lead to longer survival.
Due to considerable risk of ovarian cancer and its high lethality, women would be best advised to undergo prophylactic salpinoophorectomy, which essentially eliminates the risk of ovarian cancer.
New method extends overall survival for women with advanced ovarian cancer by about a year.
Women who drank at least two cups of tea a day had a lower risk of ovarian cancer than those who did not drink tea.
Patients with serous low grade or high grade ovarian cancer currently receive the same treatment, which is surgery followed by chemotherapy.
These findings on ovarian cancer are based on an analysis of the trial participants' initial screening tests.
Symptoms of ovarian cancer are subtle and sometimes are not recognized until it is too late for effective treatment.
More than a third of women with ovarian cancer report symptoms of the disease at least four months before diagnosis.